Clinical trial
OCS-PRECISE: Detecting and Predicting Post-stroke Cognitive Impairment
NCT07897916 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started November 2026. Observational study, 180 participants (estimated). Lead sponsor University of Copenhagen; Denmark. Primary measure: Diagnostic accuracy of the OCS: the ability of the OCS to identify cognitive impairments in the subacute... 41 linked papers (newest 2024).
How it compares
71 similar trials: same condition (Hemorrhagic Stroke) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- OCS-PRECISE: Detecting and Predicting Post-stroke Cognitive Impairment
- Lead sponsor
- University of Copenhagen
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- June 30, 2028
- Enrollment
- 180 (estimated)
- Sites
- 2
Conditions
MeSH condition names; the registry's own terms follow.
Aphasia, Cognitive Dysfunction, Fatigue, Hemorrhagic Stroke, Ischemic Stroke, Stroke
Registry terms: hemorrhagic stroke, intracerebral, post-stroke cognitive impairment (psci)
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 18 Years
- Healthy volunteers
- No
- Study type
- Observational
- Sites
- 2
- Countries
- Denmark
- Lead sponsor
- University of Copenhagen
Arms
As registered; 1 arm.
| Arm | Type | Interventions |
|---|---|---|
| OCS-Precise stroke survivors |
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Diagnostic accuracy of the OCS: the ability of the OCS to identify cognitive impairments in the subacute and chronic stage after stroke | From enrolment in the subacute stage (max three weeks post-stroke) to assessment in the chronic stage (6-9 months post-stroke). |
Show registry wordingDiagnostic accuracy will be evaluated in both the subacute and the chronic stage. First, agreement between impairment classifications using the OCS and impairment classifications on matched comprehensive neuropsychological tests will be quantified using Cohen's kappa coefficients. Second, diagnostic accuracy will be assessed by estimating sensitivity and specificity of OCS in relation to the matched comprehensive neuropsychological test battery. Impairment on a test is determined using cut-offs provided in test manuals when available or using norm-based cut-offs set at 1,5 standard deviations bellow the mean (or equivalent). | |
Papers
PubMed papers this trial cites; 41 papers, results papers first, then newest first.
+36 more papers
Lead sponsor's other trials
University of Copenhagen, most recent start first.
+460 more trials See the organization page
Similar trials
Same condition (Hemorrhagic Stroke) and phase, most recent start first.
+66 more trials See the condition page